Phenylephrine hydrochloride

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Phenylephrine hydrochloride is a potent, effective, relatively safe drug with few ocular side effects. Side effects from topical instillation are uncommon but include severe systemic cardiovascular effects with elevated blood pressure and stroke. Ten percent phenylephrine should be used with caution in patients with known cardiac disease, hypertension, aneurysms, long-standing insulin-dependent diabetes, or advanced arteriosclerosis. A 2.5% concentration is generally indicated for ophthalmic examination as well as for use in infants and in the elderly. Phenylephrine should not be used in patients with narrow-angle glaucoma, and it is also contraindicated in patients taking monoamine oxidase inhibitors or tricyclic antidepressants.

Original languageEnglish (US)
Pages (from-to)1177-1180
Number of pages4
JournalOphthalmology
Volume87
Issue number11
StatePublished - 1980

Fingerprint

Phenylephrine
Angle Closure Glaucoma
Monoamine Oxidase Inhibitors
Arteriosclerosis
Tricyclic Antidepressive Agents
Aneurysm
Heart Diseases
Stroke
Insulin
Blood Pressure
Hypertension
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Meyer, S. M., & Fraunfelder, F. F. (1980). Phenylephrine hydrochloride. Ophthalmology, 87(11), 1177-1180.

Phenylephrine hydrochloride. / Meyer, S. M.; Fraunfelder, Frederick (Fritz).

In: Ophthalmology, Vol. 87, No. 11, 1980, p. 1177-1180.

Research output: Contribution to journalArticle

Meyer, SM & Fraunfelder, FF 1980, 'Phenylephrine hydrochloride', Ophthalmology, vol. 87, no. 11, pp. 1177-1180.
Meyer, S. M. ; Fraunfelder, Frederick (Fritz). / Phenylephrine hydrochloride. In: Ophthalmology. 1980 ; Vol. 87, No. 11. pp. 1177-1180.
@article{1777c53685ca4652a87ba0ec0a42d6a6,
title = "Phenylephrine hydrochloride",
abstract = "Phenylephrine hydrochloride is a potent, effective, relatively safe drug with few ocular side effects. Side effects from topical instillation are uncommon but include severe systemic cardiovascular effects with elevated blood pressure and stroke. Ten percent phenylephrine should be used with caution in patients with known cardiac disease, hypertension, aneurysms, long-standing insulin-dependent diabetes, or advanced arteriosclerosis. A 2.5{\%} concentration is generally indicated for ophthalmic examination as well as for use in infants and in the elderly. Phenylephrine should not be used in patients with narrow-angle glaucoma, and it is also contraindicated in patients taking monoamine oxidase inhibitors or tricyclic antidepressants.",
author = "Meyer, {S. M.} and Fraunfelder, {Frederick (Fritz)}",
year = "1980",
language = "English (US)",
volume = "87",
pages = "1177--1180",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "11",

}

TY - JOUR

T1 - Phenylephrine hydrochloride

AU - Meyer, S. M.

AU - Fraunfelder, Frederick (Fritz)

PY - 1980

Y1 - 1980

N2 - Phenylephrine hydrochloride is a potent, effective, relatively safe drug with few ocular side effects. Side effects from topical instillation are uncommon but include severe systemic cardiovascular effects with elevated blood pressure and stroke. Ten percent phenylephrine should be used with caution in patients with known cardiac disease, hypertension, aneurysms, long-standing insulin-dependent diabetes, or advanced arteriosclerosis. A 2.5% concentration is generally indicated for ophthalmic examination as well as for use in infants and in the elderly. Phenylephrine should not be used in patients with narrow-angle glaucoma, and it is also contraindicated in patients taking monoamine oxidase inhibitors or tricyclic antidepressants.

AB - Phenylephrine hydrochloride is a potent, effective, relatively safe drug with few ocular side effects. Side effects from topical instillation are uncommon but include severe systemic cardiovascular effects with elevated blood pressure and stroke. Ten percent phenylephrine should be used with caution in patients with known cardiac disease, hypertension, aneurysms, long-standing insulin-dependent diabetes, or advanced arteriosclerosis. A 2.5% concentration is generally indicated for ophthalmic examination as well as for use in infants and in the elderly. Phenylephrine should not be used in patients with narrow-angle glaucoma, and it is also contraindicated in patients taking monoamine oxidase inhibitors or tricyclic antidepressants.

UR - http://www.scopus.com/inward/record.url?scp=0019226204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019226204&partnerID=8YFLogxK

M3 - Article

C2 - 7243210

AN - SCOPUS:0019226204

VL - 87

SP - 1177

EP - 1180

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 11

ER -